LATE INFANTILE METACHROMATIC LEUKODYSTROPHY
Clinical trials for LATE INFANTILE METACHROMATIC LEUKODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LATE INFANTILE METACHROMATIC LEUKODYSTROPHY trials appear
Sign up with your email to follow new studies for LATE INFANTILE METACHROMATIC LEUKODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental enzyme therapy tested in rare brain disease after transplant
Disease control CompletedThis study tested an experimental drug called METAZYM (a lab-made enzyme) in one child with late infantile metachromatic leukodystrophy (MLD) who had already received a stem cell transplant. The goal was to see if the enzyme could improve nerve function and reduce harmful buildup…
Matched conditions: LATE INFANTILE METACHROMATIC LEUKODYSTROPHY
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New MRI study maps rare brain disease in children
Knowledge-focused CompletedThis study used powerful MRI scans to track how a rare genetic disease called metachromatic leukodystrophy (MLD) damages the brain's white matter in young children. Researchers studied 29 children aged 1 to 6 years with MLD, along with a control group, to better understand how th…
Matched conditions: LATE INFANTILE METACHROMATIC LEUKODYSTROPHY
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC